MUMBAI, India, Nov. 2 -- Intellectual Property India has published a patent application (202617096806 A) filed by Hangzhou Zhongmeihuadong Pharmaceutical Co. , Ltd. on August 11, 2026, for Pharmaceutical Composition Of Long-Acting Glp-1/Gip Dual Agonist.
Inventors include Zhang, Nan; Li, Honghao; Yang, Yuanyuan; Teng, Li; Jiang, Chunhua; and Liu, Dongzhou.
The application for the patent was published on October 30, 2026, under issue no. 44/2026.
Abstract: A pharmaceutical composition comprising a long-acting GLP-1/GIP dual agonist, a kit comprising the pharmaceutical composition, and use of the pharmaceutical composition in the preparation of a drug for treating diabetes or obesity.
Disclaimer: Curated by HT Syndication....